Alpine Immune Sciences General and Administrative Expenses 2011-2026 | ALPN

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Alpine Immune Sciences

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
18 M	14.6 M	10.9 M	9.47 M	8.36 M	6.08 M	8.59 M	6.84 M	2.29 M	2.14 M	1.93 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18 M	1.93 M	8.1 M

Quarterly General and Administrative Expenses Alpine Immune Sciences

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
7.27 M	-	5.44 M	5.01 M	5.4 M	-	4.61 M	4.19 M	4.78 M	-	3.47 M	3.29 M	3.26 M	-	2.73 M	3.34 M	1.78 M	-	2.47 M	2.55 M	2.34 M	-	1.86 M	1.88 M	2.11 M	-	1.93 M	2.07 M	873 K	2.17 M	299 K	2.17 M	2.37 M	2.34 M	1.82 M	1.39 M	1.3 M	664 K	490 K	594 K	539 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.27 M	299 K	2.61 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Graybug Vision GRAY	7.89 M	-	-11.23 %	$ 9.65 M	USA
AbCellera Biologics ABCL	83.2 M	$ 3.67	-1.21 %	$ 1.1 B	Canada
ADMA Biologics ADMA	91.6 M	$ 16.57	1.16 %	$ 3.95 B	USA
I-Mab IMAB	900 M	-	-	$ 866 M	China
Apellis Pharmaceuticals APLS	550 M	$ 19.98	-0.87 %	$ 2.52 B	USA
Aptorum Group Limited APM	5.41 M	$ 0.8	1.03 %	$ 4.36 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Ampio Pharmaceuticals AMPE	7.08 M	-	-11.43 %	$ 502 K	USA
Athersys ATHX	20.1 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	60.8 M	-	-	$ 521 M	USA
Brainstorm Cell Therapeutics BCLI	7.04 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	99.3 M	$ 8.39	-1.87 %	$ 1.39 B	Britain
Axsome Therapeutics AXSM	63.3 M	$ 165.17	0.68 %	$ 8.22 B	USA
BridgeBio Pharma BBIO	531 M	$ 65.96	2.22 %	$ 12.6 B	USA
Adverum Biotechnologies ADVM	63.1 M	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	52 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
BioLineRx Ltd. BLRX	4.31 M	$ 2.84	1.07 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.15 B	$ 60.93	4.1 %	$ 11.7 B	USA
Checkpoint Therapeutics CKPT	20.1 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	12.1 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	128 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
Checkmate Pharmaceuticals CMPI	15.7 M	-	-	$ 231 M	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	84.8 M	-	-	$ 1.2 B	USA
CohBar CWBR	6.45 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	5.39 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	5.39 M	-	-4.36 %	$ 27 M	USA
Cabaletta Bio CABA	19.2 M	$ 3.38	4.0 %	$ 3.95 M	USA
Deciphera Pharmaceuticals DCPH	136 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	100 M	-	-	$ 867 M	Germany
Capricor Therapeutics CAPR	12.8 M	$ 26.52	2.63 %	$ 710 M	USA
Aeterna Zentaris AEZS	5.92 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	55.1 M	$ 1.08	9.69 %	$ 79.3 M	USA
Certara CERT	85.4 M	$ 7.26	0.21 %	$ 1.16 B	USA
Aeglea BioTherapeutics AGLE	47.9 M	-	-	$ 1.01 B	USA
Coherus BioSciences CHRS	192 M	$ 1.78	7.96 %	$ 168 M	USA
Entasis Therapeutics Holdings ETTX	15.2 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	15 M	-	7.55 %	$ 38.1 M	USA